Key result
Takotsubo cardiomyopathy therapies may guide adult donor care given shared cardiac changes after brain death.
Why the study?
Takotsubo cardiomyopathy shares histopathological and clinical similarities with cardiac changes after brain death, suggesting potential implications for adult donor care.
Takotsubo cardiomyopathy shares pathophysiological similarities with cardiac changes after brain death, suggesting that alternative circulatory support and preemptive receptor blockade may be relevant for adult donor care.
May support testing Takotsubo therapies for donor heart dysfunction; leaves open clinical efficacy in brain death.
Takotsubo cardiomyopathy, the syndrome caused by an extreme release and circulation of catecholamines, shares several histopathological and clinical similarities with cardiac changes after brain death noted in animal investigations and human observation. Overwhelming stimulation of myocardial inotropic β receptors may alter their responsiveness and induce other biochemical processes, producing reduced cardiac contractility. Treatment methods in Takotsubo cardiomyopathy that use extracorporeal circulatory support and medications that do not rely on β-receptor stimulation and preemptive blockade of β receptors or calcium channels before brain death may be relevant to donor care.
No takes yet. Share an insight, caveat, or question.
Powner et al. (2011) conducted a review in Takotsubo cardiomyopathy. Treatment methods for Takotsubo cardiomyopathy was evaluated. Takotsubo cardiomyopathy shares similarities with cardiac changes after brain death, suggesting that its treatment methods may be relevant to adult donor care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: